Supplements are not tested for interactions before they reach store shelves. Many have measurable effects on the same pathways as your prescriptions. InteractSafe documents what the research actually shows — sourced from FDA and NIH, reviewed by a retired pharmacist.
Not medical advice. This page is for educational awareness only. It does not replace consultation with your pharmacist or physician. Never start, stop, or change any medication or supplement based on what you read here. If you have questions about your specific regimen, talk to the pharmacist who can see your full prescription list.
Seven pharmacist-reviewed interaction profiles. One supplement that millions of adults are adding to prescription routines without a conversation first.
A supplement with real pharmacological activity — and a profile most people never check before adding it to a full prescription lineup.
Berberine is not a new discovery. It has been extracted from barberry and related plants for centuries and is well-documented in traditional Chinese and Ayurvedic medicine. What is relatively new is the scale of its use in the United States as a standalone supplement — driven almost entirely by a 2022–2023 social media cycle that positioned it as a low-cost alternative to GLP-1 medications.
That framing — "nature's Ozempic" — was imprecise. But it put berberine in the hands of exactly the population most likely to already be on metformin, a statin, a blood pressure medication, or a GLP-1 drug. And unlike prescription medications, berberine does not come with a pharmacist review before it leaves the shelf.
The same properties that make berberine biologically active also make it capable of interfering with how your liver processes other drugs. Berberine inhibits a family of enzymes — CYP3A4, CYP2D6, and CYP2C9 — that are responsible for metabolizing a substantial portion of commonly prescribed medications. When those enzymes are inhibited, drug concentrations in the bloodstream can rise in ways that were not part of your prescriber's calculation.
This is not unique to berberine. Grapefruit does the same thing to statins. St. John's Wort runs in reverse — it speeds up enzyme activity and reduces drug levels. The mechanism is well-understood. What varies is whether anyone checks it before a patient starts a supplement.
Both lower blood glucose through overlapping but distinct mechanisms. The concern is not that they cancel each other out — it's that they may work more powerfully together than your prescriber calibrated for. Blood sugar management with both requires monitoring and clinical awareness.
View full profile →The most-searched new combination on InteractSafe. GLP-1 medications and berberine affect metabolic function through different pathways, but both influence blood sugar and glucose regulation. Clinical data on this specific combination is still limited. This is a conversation to have with whoever manages your GLP-1 prescription before you start the supplement.
View full profile →CYP3A4 metabolizes most lipophilic statins. Berberine inhibits CYP3A4. The practical result is that statin levels in the bloodstream may increase. Whether that matters depends on which statin you take, your dose, and your individual liver function — which is exactly the kind of thing a pharmacist can look at with your specific medication list in front of them.
Warfarin's effectiveness depends on staying within a narrow therapeutic range — too little and clotting risk rises, too much and bleeding risk rises. Berberine inhibits CYP2C9, a primary enzyme in warfarin metabolism. Case reports have documented INR changes when berberine was added to anticoagulation regimens. Anyone on warfarin should treat any new supplement as a conversation with their anticoagulation provider first, not after.
Berberine lowers blood pressure independently. Layering it onto a prescription antihypertensive regimen can push blood pressure lower than your prescriber designed for — which in adults over 60 translates to dizziness, orthostatic hypotension, and fall risk. This is not theoretical. It is a straightforward pharmacological overlap that warrants a clinical conversation.
Educational reference. Source: InteractSafe pharmacist-reviewed profiles, FDA DailyMed, NIH PubMed. Not individualized advice.
| Drug / Drug Class | Why It Matters | InteractSafe Rating |
|---|---|---|
| Metformin | Additive glucose-lowering; overlapping mechanisms | Moderate |
| Semaglutide / Tirzepatide | Overlapping metabolic effects; limited combined data | Major |
| Statins (CYP3A4-metabolized) | CYP3A4 inhibition may increase statin blood levels | Moderate |
| Warfarin | CYP2C9 inhibition; documented INR changes | High Awareness |
| Antihypertensives | Additive blood pressure reduction; fall risk in 60+ | Moderate |
| Cyclosporine / Tacrolimus | CYP3A4 inhibition; narrow therapeutic window drugs | High Awareness |
| Glipizide / Glimepiride | Additive hypoglycemic effect; blood sugar monitoring | Moderate |
Pharmacist-reviewed profiles for the supplements that show up most often alongside common prescriptions — and that most patients never mention to their doctor.
Activates CYP3A4 and P-glycoprotein — running in the opposite direction from berberine. This speeds up drug clearance and reduces the effectiveness of antidepressants, blood thinners, birth control, and more. One of the most clinically significant herb-drug interactions documented. 12+ profiles in the tool.
View Profiles →Contains monacolin K — a compound structurally identical to the active ingredient in lovastatin. Adding it on top of a prescription statin is effectively doubling up on a statin without a prescription, without dose calibration, and without monitoring.
View in Tool →Warfarin works by blocking Vitamin K. Changes in how much Vitamin K you get — from food, supplements, or multivitamins — directly affect how well warfarin controls clotting. Consistency matters more than the amount. 8+ profiles in the tool.
View Profile →Popular for memory and circulation. Has antiplatelet properties — it inhibits platelet-activating factor. Combining it with blood thinners or antiplatelet medications can amplify bleeding risk beyond what either substance produces alone.
View in Tool →At typical doses, usually low concern. At higher therapeutic doses (3g+ daily), fish oil has measurable antiplatelet effects that can matter for anyone on warfarin, aspirin therapy, or other anticoagulants. The dose is the story here. 8+ profiles in the tool.
View Profiles →Widely assumed to be completely benign. Has documented interactions with antihypertensives, blood thinners, and sedative medications — particularly at doses above 1mg, which is most of what's sold in US supplement aisles. 10+ profiles in the tool.
View Profiles →Rarely discussed in the context of interactions, but timing matters. Magnesium can chelate (bind) certain antibiotics, bisphosphonates, and thyroid medications in the gut — reducing their absorption. Spacing away from other medications is often the simple fix. 9+ profiles in the tool.
View Profiles →At culinary amounts, the interaction risk is minimal. Supplemental doses of curcumin are a different story — particularly regarding anticoagulants, antiplatelet drugs, and medications processed through CYP1A2 and CYP3A4. Context is everything with this one.
View in Tool →This is not a failure of common sense. It is a structural problem with how supplement safety is handled in the United States.
Prescription drugs require clinical trials demonstrating safety and efficacy before FDA approval. Dietary supplements do not. A manufacturer can put a supplement on shelves without ever testing it against the drugs their customers are already taking.
Patients who would never combine two prescriptions without checking will add a supplement to their lineup without a second thought. Biologically active compounds don't stop being active because they come from a plant. The pharmacology doesn't care about the label.
When a pharmacist runs a drug interaction check at the counter, it only catches what's in the prescription database. Supplements bought at a grocery store or ordered online don't appear. The check comes back clean because nothing flagged — not because there's nothing to flag.
This demographic takes more prescription medications than any other age group and is also among the highest users of dietary supplements. The intersection of those two facts is precisely the problem InteractSafe was built to address.
Sourced from the most-searched supplement interaction questions on InteractSafe. Not medical advice — always verify with your pharmacist.
Not medical advice. Discuss any supplement with your pharmacist or prescriber before starting.
Not medical advice. Discuss with your physician or pharmacist before combining.
Not medical advice. Discuss with your prescriber before adding berberine to a GLP-1 regimen.
Not medical advice. Consult your anticoagulation provider before adding any supplement to a warfarin regimen.
Not medical advice.
Not medical advice.
Not medical advice.